Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Oct;12(5):759-66.
doi: 10.1188/08.CJON.759-766.

Symptom management in hepatocellular carcinoma

Virginia Chih-Yi Sun  1 , Linda Sarna
Affiliations

Symptom management in hepatocellular carcinoma

Virginia Chih-Yi Sun et al. Clin J Oncol Nurs. 2008 Oct.

Abstract

Hepatocellular carcinoma (HCC) annually causes about one million deaths. Because of advanced stage at diagnosis, HCC carries a five-year survival rate of less than 5% in patients diagnosed with unresectable disease. Incidence for HCC is higher in men and individuals of Asian descent, where viral hepatitis, a leading cause of HCC, is endemic. This article will provide an overview of the complex symptom management of patients with HCC. The occurrence of multiple symptoms, including pain, fatigue, weight loss, and obstructive syndromes (e.g., ascites, jaundice) in patients with HCC is common. Because of limitations in the efficacy of current treatment options, aggressive symptom management is key to preserving physical functioning and quality of life in patients with HCC. A multidisciplinary team approach to symptom management of patients with HCC is critical, with oncology nurses playing an integral role.

PubMed Disclaimer

References

    1. Bartlett DL, Carr BI, Marsh JW. Cancer of the liver. In: DeVita J, Vincent T, Hellman S, Rosenberg SA, editors. Cancer: Principles & practice of oncology. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. pp. 986–1008.
    1. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology. 2004;127 5 Suppl 1:S5–S16. - PubMed
    1. Bruera E, Valero V, Driver L, Shen L, Willey J, Zhang T, et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. Journal of Clinical Oncology. 2006;24(13):2073–2078. - PubMed
    1. Cahill BA, Braccia D. Current treatment for hepatocellular carcinoma. Clin J Oncol Nurs. 2004;8(4):393–399. - PubMed
    1. Carr BI. Hepatocellular carcinoma: Current management and future trends. Gastroenterology. 2004;127 5 Suppl 1:S218–S224. - PubMed

Publication types

MeSH terms